Perspective Therapeutics (AMEX:CATX) Stock Quotes, Forecast and News Summary

Q: What sector and industry does Perspective Therapeutics (CATX) operate in?

Perspective Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

Perspective Therapeutics Stock (AMEX: CATX) stock price, news, charts, stock research, profile.

Open	$2.81
Close	-
Volume / Avg.	686.43K / 1.54M
Day Range	$2.80 - $2.96
52 Wk Range	2.60 - 19.05
Market Cap	$194.65M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	19
Short Interest	18.81%
Days to Cover	2.37

Recent News

Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings

Avi Kapoor

Positive Outlook For Novartis As Company Capitalizes On Growing Treatment Opportunities, Analyst Highlights

Novartis aims to enhance Pluvicto's market presence while exploring growth in multiple sclerosis and expanding its radioligand therapy portfolio.

Vandana Singh

S&P 500 Moves Higher; BlackRock Reports Upbeat Results

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Analyst Trends and Forecast

Aug

Sep

Oct

Nov

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

4.1

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Open	$2.81
Close	-
Volume / Avg.	686.43K / 1.54M
Day Range	$2.80 - $2.96
52 Wk Range	2.60 - 19.05
Market Cap	$194.65M
P/E Ratio	-
Dividend Yield	-
Exchange	AMEX
RSI	19
Short Interest	18.81%
Days to Cover	2.37

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

How do I buy Perspective Therapeutics (CATX) stock?

You can purchase shares of Perspective Therapeutics (AMEX:CATX) through any online brokerage.

View our list of the best stock brokerages

Who are Perspective Therapeutics (CATX) competitors?

Other companies in Perspective Therapeutics’s space includes: Macrogenics (NASDAQ:MGNX), Molecular Partners (NASDAQ:MOLN), Innate Pharma (NASDAQ:IPHA), Invizyne Technologies (NASDAQ:IZTC) and Precigen (NASDAQ:PGEN).

What is the forecast, or price target, for Perspective Therapeutics (CATX) stock?

Perspective Therapeutics has a consensus price target of $11.59.

What is the current price for Perspective Therapeutics (CATX)?

The stock price for Perspective Therapeutics (AMEX: CATX) is $2.8799 last updated December 20, 2024 at 3:27 PM EST.

Does Perspective Therapeutics (CATX) pay a dividend?

There are no upcoming dividends for Perspective Therapeutics.

When is Perspective Therapeutics (AMEX:CATX) reporting earnings?

Perspective Therapeutics’s Q4 earnings are confirmed for Wednesday, February 12, 2025.

Is Perspective Therapeutics (CATX) going to split?

There is no upcoming split for Perspective Therapeutics.

What sector and industry does Perspective Therapeutics (CATX) operate in?

Perspective Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the AMEX.

Comments

Perspective Therapeutics

Perspective Therapeutics (CATX) Forecast